Swiss National Bank - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2024$2,003,407
-8.3%
97,300
-5.0%
0.00%
-50.0%
Q1 2024$2,184,192
+48.3%
102,4000.0%0.00%
+100.0%
Q4 2023$1,472,512
+32.2%
102,400
-16.1%
0.00%0.0%
Q3 2023$1,113,552
-7.8%
122,100
+6.9%
0.00%0.0%
Q2 2023$1,208,236
-21.2%
114,200
-8.9%
0.00%0.0%
Q1 2023$1,532,419
-10.1%
125,300
-8.7%
0.00%0.0%
Q4 2022$1,703,893
-6.7%
137,300
+2.7%
0.00%0.0%
Q3 2022$1,826,000
-25.5%
133,7000.0%0.00%
-50.0%
Q2 2022$2,451,000
+14.0%
133,7000.0%0.00%
+100.0%
Q1 2022$2,150,000
+23.8%
133,700
+7.7%
0.00%0.0%
Q4 2021$1,737,000
-25.3%
124,1000.0%0.00%0.0%
Q3 2021$2,324,000
-10.2%
124,1000.0%0.00%
-50.0%
Q2 2021$2,587,000
-27.3%
124,100
-1.4%
0.00%0.0%
Q1 2021$3,559,000
-11.9%
125,900
+1.8%
0.00%
-33.3%
Q4 2020$4,040,000
+18.8%
123,700
+11.4%
0.00%0.0%
Q3 2020$3,401,000
+90.5%
111,000
+1.4%
0.00%
+50.0%
Q2 2020$1,785,000
+172.1%
109,500
+66.2%
0.00%
+100.0%
Q1 2020$656,000
-26.5%
65,900
+1.5%
0.00%0.0%
Q4 2019$892,000
-4.2%
64,900
+5.7%
0.00%0.0%
Q3 2019$931,000
-23.0%
61,4000.0%0.00%0.0%
Q2 2019$1,209,000
+61.6%
61,400
+36.1%
0.00%0.0%
Q1 2019$748,000
+26.4%
45,100
+6.9%
0.00%0.0%
Q4 2018$592,000
-19.9%
42,2000.0%0.00%0.0%
Q3 2018$739,000
-3.8%
42,2000.0%0.00%0.0%
Q2 2018$768,00042,2000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders